Insider filing · RGEN
Olivier Loeillot
Chief Executive Officer
profile →
Repligen Corporation
RGEN · Healthcare · 16 filings in 24 months
ticker →
Olivier Loeillot sold $1.2M of Repligen (RGEN)
Executed Nov 25 2025, disclosed Nov 26 2025, 1 day later.
Value, as filed
$1.2M
7,041 sh × $170.00
Executed
Nov 25 2025
the trade date, as filed
Disclosed
Nov 26 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
OLOlivier Loeillot (Chief Executive Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Repligen Corporation (RGEN). The largest single filing was $1.2M of RGEN (7,041 sh × $170.00, as filed), executed Nov 25 2025.
The name
RGENHealthcare · Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Olivier Loeillot in RGEN
RGENSALE
Repligen Corporation
$977K5,426 sh × $180.00
Exec Sep 21
Filed Sep 22 · 4:07 PM ET RGENSALE Repligen Corporation $504K
3,035 sh × $165.90
Exec Sep 4
Filed Sep 8 · 4:13 PM ET RGENSALE Repligen Corporation $977K
5,426 sh × $180.00
Exec Aug 20
Filed Aug 21 · 4:06 PM ET RGENSALE Repligen Corporation $536K
3,832 sh × $140.00
Exec Apr 21
Filed Apr 22 · 5:30 PM ET